Vanberra Signal

DxNow

Curated by Signal

Portable Bio-imaging Systems & Microfluidic-Based Consumables

Overview

DxNow develops portable bio-imaging systems based on microfluidic technology based consumables for application in life science industry. The technology is based on the proprietary technology developed in Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. The company's product line includes CE marked FERTILE (Microfluidic sperm sorting chips) for ICSI and FERTILE PLUS for ICSI, IUI and IVF, CSI-Q, a Chip-based sperm identification and quantitation cartridges, and NGDE (Next-Generation Differential Extraction) system.

Key facts

Founded
2013

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Digital electronic medical record system for providers

    Health TechnologyLisle, United States
  • Provider of customized live fitness and nutrition programs

    Health TechnologyUnited States
  • SaaS-based application for the clinical trial industry

    Health TechnologyWoburn, United States

About DxNow

What does DxNow do?

DxNow develops portable bio-imaging systems based on microfluidic technology based consumables for application in life science industry.

Where is DxNow headquartered?

DxNow is headquartered in Gaithersburg, United States.

When was DxNow founded?

DxNow was founded in 2013.

Which sector is DxNow in?

DxNow operates in Health Technology.

Who are DxNow's competitors?

Companies similar to DxNow include Isoprime Corporation, MERCFIT, and QuantiNova.